Tempest Therapeutics, Inc. (TPST) stock
TPSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.31−0.02 (-5.50%)
Close on Nov 18, 2026Market cap $4.58MP/E –Yield –
Tempest Therapeutics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Tempest Therapeutics's free cash flow for the twelve months ending Jun 30, 2026 was -$20.73M. For fiscal 2025 it was -$26.82M. The highest annual figure on record is -$12.01M in fiscal 2012.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$26.82M | – |
| FY2024 | Dec 31, 2024 | -$33.46M | – |
| FY2023 | Dec 31, 2023 | -$27.53M | – |
| FY2022 | Dec 31, 2022 | -$31.63M | – |
| FY2021 | Dec 31, 2021 | -$26.09M | – |
| FY2020 | Dec 31, 2020 | -$19.07M | – |
| FY2019 | Dec 31, 2019 | -$41.62M | – |
| FY2018 | Dec 31, 2018 | -$23.68M | – |
| FY2017 | Dec 31, 2017 | -$20.34M | – |
| FY2016 | Dec 31, 2016 | -$64.32M | – |
| FY2015 | Dec 31, 2015 | -$55.52M | – |
| FY2014 | Dec 31, 2014 | -$33.39M | – |
| FY2013 | Dec 31, 2013 | -$18.81M | – |
| FY2012 | Dec 31, 2012 | -$12.01M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.78M | – |
| Q1 FY2026 | Mar 31, 2026 | -$7.60M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.57M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.78M | – |
| Q2 FY2025 | Jun 30, 2025 | -$8.43M | – |
| Q1 FY2025 | Mar 31, 2025 | -$8.04M | – |
| Q4 FY2024 | Dec 31, 2024 | -$10.15M | – |
| Q3 FY2024 | Sep 30, 2024 | -$10.20M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.76M | – |
| Q1 FY2024 | Mar 31, 2024 | -$7.35M | – |
| Q4 FY2023 | Dec 31, 2023 | -$6.18M | – |
| Q3 FY2023 | Sep 30, 2023 | -$6.49M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.51M | – |
| Q1 FY2023 | Mar 31, 2023 | -$8.35M | – |
| Q4 FY2022 | Dec 31, 2022 | -$6.84M | – |
| Q3 FY2022 | Sep 30, 2022 | -$9.18M | – |
| Q2 FY2022 | Jun 30, 2022 | -$8.51M | -15028.1% |
| Q1 FY2022 | Mar 31, 2022 | -$7.11M | – |
| Q4 FY2021 | Dec 31, 2021 | -$8.01M | – |
| Q3 FY2021 | Sep 30, 2021 | -$11.81M | – |
| Q2 FY2021 | Jun 30, 2021 | $57.00K | +96.6% |
| Q1 FY2021 | Mar 31, 2021 | -$6.32M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.28M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.63M | – |
| Q2 FY2020 | Jun 30, 2020 | $29.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$10.19M | – |
| Q4 FY2019 | Dec 31, 2019 | -$11.72M | – |
| Q3 FY2019 | Sep 30, 2019 | -$8.44M | – |
| Q2 FY2019 | Jun 30, 2019 | -$10.84M | – |
| Q1 FY2019 | Mar 31, 2019 | -$10.61M | – |
| Q4 FY2018 | Dec 31, 2018 | -$9.24M | -153.3% |
| Q3 FY2018 | Sep 30, 2018 | -$4.74M | – |
| Q2 FY2018 | Jun 30, 2018 | -$4.71M | – |
| Q1 FY2018 | Mar 31, 2018 | -$5.00M | – |
| Q4 FY2017 | Dec 31, 2017 | $17.35M | – |
| Q3 FY2017 | Sep 30, 2017 | -$10.32M | – |
| Q2 FY2017 | Jun 30, 2017 | -$12.12M | – |
| Q1 FY2017 | Mar 31, 2017 | -$15.26M | – |
| Q4 FY2016 | Dec 31, 2016 | -$16.51M | – |
| Q3 FY2016 | Sep 30, 2016 | -$15.61M | – |
See a number that looks wrong?